Clinical Trials

85 enrolled

Lymphatic Metastasis

NCT06451445 2025-12-11

WIRED

100 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07191548 2025-10-10

LIVERMET-IRE

50 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular, Liver Diseases

NCT07192731 2025-10-10

LIVERHCC-IRE

50 enrolled

Carcinoma, Hepatocellular

NCT04276857 2025-05-13

SMART

27 enrolled

Locally Advanced Pancreatic Cancer

NCT04972097 2025-02-12

PRESERVE

121 enrolled

Prostatic Neoplasms

NCT05513443 2025-01-20

PRIS

184 enrolled

Prostatic Neoplasms

NCT02791503 2022-12-20

CROSSFIRE

74 enrolled

Pancreatic Neoplasms

NCT05512663 2022-08-23

Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer

10 enrolled

Prostatic Neoplasms

NCT03257150 2022-08-11

A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

12 enrolled

Pancreatic Ductal Adenocarcinoma

NCT04717687 2022-07-13

HOPE

Cholangiocarcinoma

NCT02329106 2021-09-05

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Liver Neoplasms

NCT02333773 2021-09-05

IRE

15 enrolled

Liver Neoplasms

NCT02335112 2021-09-05

IRE

15 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02335827 2021-09-05

IRE

15 enrolled

Carcinoma, Renal Cell

NCT02425059 2021-09-05

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Rectal Neoplasms

NCT02430597 2021-09-05

IRE

Hilus Pulmonary Neoplasms

NCT02430610 2021-09-05

IRE

Gynecologic

Uterine Cervical Neoplasms

NCT02430623 2021-09-05

IRE

Urinary Bladder Neoplasms

NCT02430636 2021-09-05

IRE

Stomach Neoplasms

NCT02430662 2021-09-05

IRE

Gallbladder Neoplasms

NCT02430675 2021-09-05

IRE

Head & Neck

Laryngeal Neoplasms

NCT02430688 2021-09-05

IRE

Extremities Neoplasms

NCT02430701 2021-09-05

IRE

Esophageal Neoplasms

NCT02430753 2021-09-05

IRE

Thoracic

Lung Neoplasms

NCT02430766 2021-09-05

IRE

Lymphatic Metastasis

NCT02430779 2021-09-05

IRE

Ureteral Neoplasms

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

Pancreatic Adenocarcinoma Resectable

NCT04093141 2021-04-01

CHEMOFIRE-2

Unresectable Pancreatic Cancer

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT02981719 2021-01-22

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

61 enrolled

Pancreatic Neoplasms

NCT03040453 2020-11-30

IRAL

Carcinoma, Hepatocellular

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

18 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02841436 2020-07-07

A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer

7 enrolled

Pancreatic Neoplasms

NCT02430649 2020-05-27

IRE

Prostatic Neoplasms

NCT04310553 2020-03-17

An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

240 enrolled

Pancreatic Neoplasms

NCT02898649 2019-02-15

Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer

100 enrolled

Locally Advanced Pancreatic Cancer

NCT03169439 2017-05-30

Irreversible Electroporation for Treatment of Solid Abdominal Tumors

25 enrolled

Tumor-Agnostic

Neoplasms

NCT01726894 2014-06-18

Nano

20 enrolled

Prostatic Neoplasms

NCT02010801 2013-12-13

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

20 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01442324 2012-07-18

Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma

5 enrolled